EXTREME FAT BURN 5 mg x 5 Vials – Biomolecule

Description

Biomolecule EXTREME FAT BURN 5 mg is a multi-peptide research formulation combining four different peptides associated with growth hormone pathways, metabolic research, and body-fat-related biological processes. The listed formulation contains HGH Fragment, AOD-9604, Adipotide, and Sermorelin.

This combination brings together peptides that have attracted scientific interest for different reasons. HGH Fragment and AOD-9604 are associated with research into growth hormone-derived sequences and fat metabolism. Adipotide is an investigational peptide studied in relation to targeted fat-cell biology, while Sermorelin is a synthetic analogue of growth hormone-releasing hormone (GHRH).

Rather than treating all four compounds as having the same mechanism, it is important to understand their individual research backgrounds. Their combination has not been established as a clinically proven fat-loss treatment, and the safety and effectiveness of this specific formulation have not been demonstrated in adequate human trials.

Key Ingredients and Composition

Total Listed Composition: 5 mg

1. HGH Fragment – 2 mg

HGH Fragment refers to a peptide sequence derived from human growth hormone. Fragment-based compounds have been investigated for their potential involvement in fat-metabolism pathways.

Research interest includes lipolysis, the biological process through which stored fats are broken down. However, HGH Fragment should not be confused with full-length human growth hormone, and its fat-loss effectiveness in humans has not been established.

2. AOD-9604 – 1 mg

AOD-9604 is a synthetic peptide derived from the C-terminal region of human growth hormone. It was originally investigated as a potential anti-obesity compound, with research focusing on fat metabolism and lipolysis.

Although early laboratory findings generated interest, clinical development did not establish meaningful weight-loss effectiveness. The FDA has also identified important safety-information gaps and potential immunogenicity concerns regarding compounded AOD-9604 products.

3. Adipotide – 1 mg

Adipotide is an investigational peptide studied for its proposed interaction with blood vessels associated with adipose tissue. Its research has focused on targeted biological mechanisms involving fat tissue rather than conventional appetite regulation.

Adipotide remains experimental, and its safety and effectiveness as a human weight-management treatment have not been established. It should not be described as a proven fat-burning ingredient.

4. Sermorelin – 1 mg

Sermorelin is a synthetic analogue of growth hormone-releasing hormone (GHRH). It interacts with GHRH receptors and stimulates the body’s own growth hormone release.

Sermorelin has been investigated in relation to growth hormone regulation, IGF-1 pathways, and endocrine function. Its mechanism is different from that of HGH Fragment and AOD-9604, making it a distinct component of this combination.

Product Benefits and Research Areas

• Fat-metabolism research: Investigates biological pathways involved in fat breakdown and storage.
• Lipolysis research: Explores mechanisms associated with the release of stored fatty acids.
• Adipose tissue research: Examines biological processes involving fat cells and their surrounding tissue.
• Growth hormone research: Investigates hormonal pathways associated with growth hormone regulation.
• GHRH pathway research: Studies the interaction between Sermorelin and growth hormone-releasing hormone receptors.
• Metabolic research: Provides a combination of compounds for investigating different metabolic and endocrine pathways.

Important Safety Information

EXTREME FAT BURN is a combination of investigational peptides and should not be considered an approved or clinically proven weight-loss treatment. AOD-9604 has limited interpretable human efficacy evidence, while Adipotide has not established an approved human therapeutic application. Sermorelin also requires appropriate medical assessment and supervision when used as a medicine.

Potential concerns include immune reactions, unpredictable biological effects, hormonal changes, and unknown interactions between the four compounds. The safety of combining these ingredients in one formulation has not been established.

The listed composition does not establish sterility, purity, stability, or suitability for human administration. Product identity, manufacturing quality, and the actual contents of each vial should be independently verified.

This product description is for research-oriented information and is not a recommendation for human use.

Pack Details

• Product Name: EXTREME FAT BURN
• Brand: Biomolecule
• Listed Strength: 5 mg per vial
• Listed Ingredients: Four peptide compounds
• Packaging: 5 Vials
• Total Listed Composition: 25 mg across five vials, assuming the stated 5 mg formulation applies to each vial.